New research, pioneered by a first year Ph.D. student and researchers at the University of St Andrews' School of Biology, has identified an important new component of the CRISPR genome engineering ...

If the first CRISPR decade was marked by a mad dash to evolve, engineer, and mine the bacterial universe for more and better genome-editing enzymes, so far the second seems to be all about three words ...

Many foundational research technologies have transformed cellular therapies, moving treatments from concept to clinic. In the past decade, chimeric antigen receptors (CAR) and genome editing are two ...

The United Nations predicts that there will be an additional 2.2 billion people on the planet by 2050. To help feed the growing population, the food industry must overcome several critical challenges, ...

NSF CAREER award recipient Tomas Gonzalez-Fernandez, an assistant professor of bioengineering in Lehigh University’s P.C. Rossin College of Engineering and Applied Science, leads research at the ...

Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) proteins are core components of fast-evolving therapeutic gene editing tools. Scientists have used CRISPR ...

A new study published in Nucleic Acids Research unveils crucial advances in the engineering of CRISPR-associated transposons (CASTs)—a class of natural, RNA-guided DNA integration systems. According ...

In 2025, CRISPR advanced gene editing with safe, effective therapies and AI tools, marking a shift towards real-world ...

In the world of biopharmaceutical innovation, 2024 will be remembered as CRISPR’s breakout year. In the spring, five patients with sickle cell disease began treatment with Casgevy, the first ...